Alarming Antibiotics Resistance of Helicobacter Pylori from Children in Southeast China over 6 years

Overview

Journal Sci Rep

Specialty Science

Date 2022 Oct 22

PMID 36272980

Authors

Xiaoli Shu

Diya Ye

Chenmin Hu

Kerong Peng

Hong Zhao

Huamei Li

Mizu Jiang

Affiliations

Soon will be listed here.

Abstract

The increasing rates of antibiotic resistance in Helicobacter pylori (H. pylori) are a major concern of the decreasing eradication rate. Large-scale and long-period studies on antimicrobial susceptibility of H. pylori in children are limited. This study aimed to describe the temporal changes of antibiotic resistance among children in southeast China. Gastric biopsies obtained from children were cultured for H. pylori from 2015 to 2020. Susceptibility to clarithromycin (CLA), amoxicillin (AML), metronidazole (MTZ), furazolidone (FZD), tetracycline (TET) and levofloxacin (LEV) was tested. Data from 2012 to 2014 reported previously were obtained for comparing the change in temporal trends of antibiotic resistance. A total of 1638 (52.7%) H. pylori strains were isolated from 3111 children recruited. The resistance rates to CLA, MTZ and LEV were 32.8%, 81.7% and 22.8%, respectively. There were 52.9% strains resistant to single resistance, 28.7% to double resistance, and 9.0% to triple resistance. The total resistance rate and resistance rates to CLA, MTZ, LEV, CLA + LEV and CLA + MTZ + LEV increased annually in a linear manner. All resistant patterns except single resistance increased obviously from 2015 to 2017 and 2018 to 2020 compared to that from 2012 to 2014. Double resistance to CLA + MTZ increased significantly with age. The resistance rate to CLA and triple resistance to CLA, MTZ and LEV increased in children with prior H. pylori treatment than that from children without prior treatment. The antibiotic resistance rates of H. pylori were high in a large pediatric population in southeast China from 2015 to 2020. Individual treatment based on susceptibility test is imperative and optimal regimens should be chosen in H. pylori eradication therapy.

Citing Articles

Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis.

Salahi-Niri A, Nabavi-Rad A, Monaghan T, Rokkas T, Doulberis M, Sadeghi A BMC Med. 2024; 22(1):598.

PMID: 39710669 PMC: 11664859. DOI: 10.1186/s12916-024-03816-y.

antibiotic resistance profile in Chinese children with upper gastrointestinal symptoms and a literature review for developing personalized eradicating strategies.

Zhou D, Wang W, Gu L, Han M, Hao W, Huang J Front Pharmacol. 2024; 15:1392787.

PMID: 38887553 PMC: 11180794. DOI: 10.3389/fphar.2024.1392787.

Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days.

Ding Y, Duan M, Han Z, Song X, Zhang F, Wang Z Dig Dis Sci. 2024; 69(7):2540-2547.

PMID: 38700630 DOI: 10.1007/s10620-024-08460-3.

Extent of Virulence and Antibiotic Resistance Genes in Helicobacter pylori and Campylobacteria.

Rao R, Ghate S, Pinto L, Suravajhala P, Patil P, Shetty P Curr Microbiol. 2024; 81(6):154.

PMID: 38652129 DOI: 10.1007/s00284-024-03653-5.

Antibiotic resistance in Helicobacter pylori among children and adolescents in East Asia: A systematic review and meta-analysis.

Zhou Y, Zhang Y, Du S Chin Med J (Engl). 2024; 137(16):1926-1938.

PMID: 38230488 PMC: 11332731. DOI: 10.1097/CM9.0000000000002884.

References

Kim J, Reddy R, Lee M, Kim J, Osato M, Graham D . Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001; 47(4):459-61. DOI: 10.1093/jac/47.4.459. View

. [Guidelines for Helicobacter pylori infection in children in China]. Zhonghua Er Ke Za Zhi. 2015; 53(7):496-8. View

Savoldi A, Carrara E, Graham D, Conti M, Tacconelli E . Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018; 155(5):1372-1382.e17. PMC: 6905086. DOI: 10.1053/j.gastro.2018.07.007. View

Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl A . Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2012; 62(1):34-42. DOI: 10.1136/gutjnl-2012-302254. View

Liu W, Gillani A, Xu S, Chen C, Chang J, Yang C . Antibiotics (Macrolides and Lincosamides) Consumption Trends and Patterns in China's Healthcare Institutes. Based on a 3 Year Procurement Records, 2015-2017. Int J Environ Res Public Health. 2020; 18(1). PMC: 7794919. DOI: 10.3390/ijerph18010113. View

Peretz A, Paritsky M, Nasser O, Brodsky D, Glyatman T, Segal S . Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults. J Antibiot (Tokyo). 2014; 67(8):555-7. DOI: 10.1038/ja.2014.38. View

Li L, Ke Y, Yu C, Li G, Yang N, Zhang J . Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years. Helicobacter. 2017; 22(3). DOI: 10.1111/hel.12373. View

Suzuki H, Matsuzaki J . Gastric cancer: evidence boosts Helicobacter pylori eradication. Nat Rev Gastroenterol Hepatol. 2018; 15(8):458-460. DOI: 10.1038/s41575-018-0023-8. View

Li J, Deng J, Wang Z, Li H, Wan C . Antibiotic Resistance of Strains Isolated From Pediatric Patients in Southwest China. Front Microbiol. 2021; 11:621791. PMC: 7870467. DOI: 10.3389/fmicb.2020.621791. View

10.

Kato S, Shimizu T, Toyoda S, Gold B, Ida S, Ishige T . The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int. 2020; 62(12):1315-1331. PMC: 7839701. DOI: 10.1111/ped.14388. View

11.

Jones N, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T . Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 2017; 64(6):991-1003. DOI: 10.1097/MPG.0000000000001594. View

12.

Yin G, Bie S, Gu H, Shu X, Zheng W, Peng K . Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children. J Gastroenterol Hepatol. 2020; 35(8):1331-1339. DOI: 10.1111/jgh.14980. View

13.

Han X, Zhang Y, He L, Fan R, Sun L, Fan D . Genetic and Transcriptomic Variations for Amoxicillin Resistance in under Cryopreservation. Pathogens. 2021; 10(6). PMC: 8229390. DOI: 10.3390/pathogens10060676. View

14.

Megraud F, Bruyndonckx R, Coenen S, Wittkop L, Huang T, Hoebeke M . resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. Gut. 2021; 70(10):1815-1822. DOI: 10.1136/gutjnl-2021-324032. View

15.

Argueta E, Alsamman M, Moss S, DAgata E . Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population. Gastroenterology. 2021; 160(6):2181-2183.e1. PMC: 9115583. DOI: 10.1053/j.gastro.2021.02.014. View

16.

Zou Y, Qian X, Liu X, Song Y, Song C, Wu S . The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis. Helicobacter. 2020; 25(4):e12714. DOI: 10.1111/hel.12714. View

17.

Liu W, Xie Y, Lu H, Cheng H, Zeng Z, Zhou L . Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018; 23(2):e12475. DOI: 10.1111/hel.12475. View

18.

Shu X, Yin G, Liu M, Peng K, Zhao H, Jiang M . Antibiotics resistance of Helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China. Helicobacter. 2018; 23(3):e12481. DOI: 10.1111/hel.12481. View

19.

Blyth C, Gerber J . Macrolides in Children With Community-Acquired Pneumonia: Panacea or Placebo?. J Pediatric Infect Dis Soc. 2017; 7(1):71-77. DOI: 10.1093/jpids/pix083. View

20.

Zhou Y, Ye Z, Wang Y, Zhang Y, Tang Z, Yan W . Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children. Helicobacter. 2020; 25(2):e12679. DOI: 10.1111/hel.12679. View